View ValuationMedservRegis 将来の成長Future 基準チェック /06現在、 MedservRegisの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Energy Services 収益成長8.2%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Feb 03MedservRegis p.l.c. Provides Earnings Guidance for the Year Ended December 31, 2023MedservRegis p.l.c. provided earnings guidance for the year ended December 31, 2023. The group's unaudited revenues for 2023 are anticipated to be in the region of EUR 73 million, an increase of 9% compared to the EUR 66.9 million achieved in 2022 and an increase of 13.2% against the revenue forecast disclosed in the 2022 Updated Financial Analysis Summary.すべての更新を表示Recent updatesBoard Change • Jun 02Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • May 21Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 14MedservRegis p.l.c. to Report Fiscal Year 2025 Results on Apr 28, 2026MedservRegis p.l.c. announced that they will report fiscal year 2025 results at 9:32 AM, Central European Standard Time on Apr 28, 2026お知らせ • Mar 31MedservRegis p.l.c., Annual General Meeting, May 27, 2026MedservRegis p.l.c., Annual General Meeting, May 27, 2026.分析記事 • Nov 04Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 38% Price JumpMedservRegis p.l.c. ( MTSE:MDS ) shares have had a really impressive month, gaining 38% after a shaky period...分析記事 • Oct 26Is MedservRegis (MTSE:MDS) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Sep 20Market Might Still Lack Some Conviction On MedservRegis p.l.c. (MTSE:MDS) Even After 30% Share Price BoostMedservRegis p.l.c. ( MTSE:MDS ) shareholders would be excited to see that the share price has had a great month...お知らせ • Jun 27MedservRegis p.l.c. to Report First Half, 2025 Results on Aug 29, 2025MedservRegis p.l.c. announced that they will report first half, 2025 results on Aug 29, 2025分析記事 • May 22We Think Some Shareholders May Hesitate To Increase MedservRegis p.l.c.'s (MTSE:MDS) CEO CompensationKey Insights MedservRegis' Annual General Meeting to take place on 29th of May Total pay for CEO David O’Connor...お知らせ • Apr 23Medservregis P.L.C. Recommends Further Gross Dividend, Payable by No Later Than June 30, 2025MedservRegis p.l.c. Board of Directors recommended the payment of a further gross dividend for the year under review of €1.5 million, equivalent to a gross dividend of €0.014758 per share (net €0.014221 per share1), on all shares settled as at close of business on the 13 May 2025, which dividend shall be paid by no later than 30 June 2025.お知らせ • Mar 19MedservRegis p.l.c., Annual General Meeting, May 29, 2025MedservRegis p.l.c., Annual General Meeting, May 29, 2025.分析記事 • Feb 26MedservRegis p.l.c. (MTSE:MDS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some ScrutinyTo the annoyance of some shareholders, MedservRegis p.l.c. ( MTSE:MDS ) shares are down a considerable 26% in the last...分析記事 • Jan 20Estimating The Fair Value Of MedservRegis p.l.c. (MTSE:MDS)Key Insights Using the 2 Stage Free Cash Flow to Equity, MedservRegis fair value estimate is €0.43 MedservRegis' €0.50...分析記事 • Nov 28Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 32% Price JumpDespite an already strong run, MedservRegis p.l.c. ( MTSE:MDS ) shares have been powering on, with a gain of 32% in the...分析記事 • Nov 22Does MedservRegis (MTSE:MDS) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Board Change • Oct 07Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Aug 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • May 28Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Apr 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Mar 27Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 15% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€72.2m market cap, or US$78.6m).Board Change • Mar 08Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.お知らせ • Feb 03MedservRegis p.l.c. Provides Earnings Guidance for the Year Ended December 31, 2023MedservRegis p.l.c. provided earnings guidance for the year ended December 31, 2023. The group's unaudited revenues for 2023 are anticipated to be in the region of EUR 73 million, an increase of 9% compared to the EUR 66.9 million achieved in 2022 and an increase of 13.2% against the revenue forecast disclosed in the 2022 Updated Financial Analysis Summary.分析記事 • Jan 24MedservRegis p.l.c. (MTSE:MDS) Doing What It Can To Lift SharesIt's not a stretch to say that MedservRegis p.l.c.'s ( MTSE:MDS ) price-to-sales (or "P/S") ratio of 1x right now seems...Board Change • Jan 23Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Nov 01Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Emerging Markets & Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Jul 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Jun 28Full year 2022 earnings releasedFull year 2022 results: Revenue: €66.9m (up 124% from FY 2021). Net income: €545.0k (up €8.16m from FY 2021). Profit margin: 0.8% (up from net loss in FY 2021).Board Change • Jun 15Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Feb 02Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Dec 22Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Nov 22Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Oct 21Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Aug 30First half 2022 earnings released: €0.012 loss per share (vs €0.011 profit in 1H 2021)First half 2022 results: €0.012 loss per share (down from €0.011 profit in 1H 2021). Revenue: €26.1m (up 410% from 1H 2021). Net loss: €1.17m (down 295% from profit in 1H 2021).Board Change • Aug 24Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Aug 02Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Jun 21Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Jun 17MedservRegis p.l.c., Annual General Meeting, Jul 28, 2022MedservRegis p.l.c., Annual General Meeting, Jul 28, 2022. Agenda: To consider approval of the annual report 2021.Board Change • Mar 04Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Feb 03Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Jan 19Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Jan 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、MedservRegis は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測MTSE:MDS - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20251055915N/A9/30/20259451015N/A6/30/20258251114N/A3/31/20257631216N/A12/31/20247021317N/A9/30/20247211116N/A6/30/20247401016N/A3/31/20247401014N/A12/31/20237411012N/A9/30/20237321518N/A6/30/20237332023N/A3/31/20237021922N/A12/31/20226711720N/A9/30/202258-5911N/A6/30/202250-1023N/A3/31/202240-923N/A12/31/202130-824N/A6/30/202111-914N/A3/31/202111-914N/A12/31/202011-1236N/A9/30/202014-1024N/A6/30/202016-937N/A3/31/202018-1048N/A12/31/201919-714N/A9/30/2019191N/A4N/A6/30/2019184N/A3N/A3/31/2019195N/A2N/A12/31/2018176N/A4N/A12/31/2017150N/A3N/A12/31/2016248N/A19N/A12/31/20155216N/A21N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: MDSの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: MDSの収益がMT市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: MDSの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: MDSの収益がMT市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: MDSの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MDSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YEnergy 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/14 22:17終値2026/06/03 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MedservRegis p.l.c. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Feb 03MedservRegis p.l.c. Provides Earnings Guidance for the Year Ended December 31, 2023MedservRegis p.l.c. provided earnings guidance for the year ended December 31, 2023. The group's unaudited revenues for 2023 are anticipated to be in the region of EUR 73 million, an increase of 9% compared to the EUR 66.9 million achieved in 2022 and an increase of 13.2% against the revenue forecast disclosed in the 2022 Updated Financial Analysis Summary.
Board Change • Jun 02Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • May 21Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 14MedservRegis p.l.c. to Report Fiscal Year 2025 Results on Apr 28, 2026MedservRegis p.l.c. announced that they will report fiscal year 2025 results at 9:32 AM, Central European Standard Time on Apr 28, 2026
お知らせ • Mar 31MedservRegis p.l.c., Annual General Meeting, May 27, 2026MedservRegis p.l.c., Annual General Meeting, May 27, 2026.
分析記事 • Nov 04Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 38% Price JumpMedservRegis p.l.c. ( MTSE:MDS ) shares have had a really impressive month, gaining 38% after a shaky period...
分析記事 • Oct 26Is MedservRegis (MTSE:MDS) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Sep 20Market Might Still Lack Some Conviction On MedservRegis p.l.c. (MTSE:MDS) Even After 30% Share Price BoostMedservRegis p.l.c. ( MTSE:MDS ) shareholders would be excited to see that the share price has had a great month...
お知らせ • Jun 27MedservRegis p.l.c. to Report First Half, 2025 Results on Aug 29, 2025MedservRegis p.l.c. announced that they will report first half, 2025 results on Aug 29, 2025
分析記事 • May 22We Think Some Shareholders May Hesitate To Increase MedservRegis p.l.c.'s (MTSE:MDS) CEO CompensationKey Insights MedservRegis' Annual General Meeting to take place on 29th of May Total pay for CEO David O’Connor...
お知らせ • Apr 23Medservregis P.L.C. Recommends Further Gross Dividend, Payable by No Later Than June 30, 2025MedservRegis p.l.c. Board of Directors recommended the payment of a further gross dividend for the year under review of €1.5 million, equivalent to a gross dividend of €0.014758 per share (net €0.014221 per share1), on all shares settled as at close of business on the 13 May 2025, which dividend shall be paid by no later than 30 June 2025.
お知らせ • Mar 19MedservRegis p.l.c., Annual General Meeting, May 29, 2025MedservRegis p.l.c., Annual General Meeting, May 29, 2025.
分析記事 • Feb 26MedservRegis p.l.c. (MTSE:MDS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some ScrutinyTo the annoyance of some shareholders, MedservRegis p.l.c. ( MTSE:MDS ) shares are down a considerable 26% in the last...
分析記事 • Jan 20Estimating The Fair Value Of MedservRegis p.l.c. (MTSE:MDS)Key Insights Using the 2 Stage Free Cash Flow to Equity, MedservRegis fair value estimate is €0.43 MedservRegis' €0.50...
分析記事 • Nov 28Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 32% Price JumpDespite an already strong run, MedservRegis p.l.c. ( MTSE:MDS ) shares have been powering on, with a gain of 32% in the...
分析記事 • Nov 22Does MedservRegis (MTSE:MDS) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Board Change • Oct 07Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Aug 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • May 28Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Apr 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Mar 27Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 15% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€72.2m market cap, or US$78.6m).
Board Change • Mar 08Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
お知らせ • Feb 03MedservRegis p.l.c. Provides Earnings Guidance for the Year Ended December 31, 2023MedservRegis p.l.c. provided earnings guidance for the year ended December 31, 2023. The group's unaudited revenues for 2023 are anticipated to be in the region of EUR 73 million, an increase of 9% compared to the EUR 66.9 million achieved in 2022 and an increase of 13.2% against the revenue forecast disclosed in the 2022 Updated Financial Analysis Summary.
分析記事 • Jan 24MedservRegis p.l.c. (MTSE:MDS) Doing What It Can To Lift SharesIt's not a stretch to say that MedservRegis p.l.c.'s ( MTSE:MDS ) price-to-sales (or "P/S") ratio of 1x right now seems...
Board Change • Jan 23Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Nov 01Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Emerging Markets & Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Jul 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Jun 28Full year 2022 earnings releasedFull year 2022 results: Revenue: €66.9m (up 124% from FY 2021). Net income: €545.0k (up €8.16m from FY 2021). Profit margin: 0.8% (up from net loss in FY 2021).
Board Change • Jun 15Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Feb 02Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Dec 22Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Nov 22Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Oct 21Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Aug 30First half 2022 earnings released: €0.012 loss per share (vs €0.011 profit in 1H 2021)First half 2022 results: €0.012 loss per share (down from €0.011 profit in 1H 2021). Revenue: €26.1m (up 410% from 1H 2021). Net loss: €1.17m (down 295% from profit in 1H 2021).
Board Change • Aug 24Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Aug 02Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Jun 21Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Jun 17MedservRegis p.l.c., Annual General Meeting, Jul 28, 2022MedservRegis p.l.c., Annual General Meeting, Jul 28, 2022. Agenda: To consider approval of the annual report 2021.
Board Change • Mar 04Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Feb 03Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Jan 19Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Jan 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.